Supplementation ofN-Acetylcysteine Fails to Increase Glutathione in Lymphocytes and Plasma of Patients with AIDS
- 1 January 1995
- journal article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 11 (1), 141-143
- https://doi.org/10.1089/aid.1995.11.141
Abstract
Because glutathione (GSH) in plasma and lymphocytes of HIV-infected patients is low, adjunct therapy with N-acetylcysteine (NAC) to restore GSH homeostasis has been proposed. To investigate the effect of NAC on the GSH status we treated six patients with AIDS with 1.8 g/day of NAC for 2 weeks. During treatment the plasma concentration of cysteine, a precursor for GSH synthesis, increased significantly. Nevertheless, there was no significant increase in GSH in plasma and peripheral blood mononuclear cells. The failure of sulfhydryl supplementation to increase GSH suggests that the low concentrations of the tripeptide are not the result of an increased consumption secondary to an oxidant stress, but rather the consequence of a decreased rate of synthesis of GSH in HIV infection.Keywords
This publication has 24 references indexed in Scilit:
- Antioxidants Inhibit Stimulation of HIV TranscriptionAIDS Research and Human Retroviruses, 1993
- N-Acetylcysteine: Potential for AIDS TherapyPharmacology, 1993
- Glutathione depletion in HIV-infected patientsAIDS, 1992
- Glutathione deficiency and human immunodeficiency virus infectionThe Lancet, 1992
- HIV-induced cysteine deficiency and T-cell dysfunction — a rationale for treatment with N-acetylcysteineImmunology Today, 1992
- Macrophages regulate intracellular glutathione levels of lymphocytes. Evidence for an immunoregulatory role of cysteineCellular Immunology, 1990
- Influence of the Extracellular Glutamate Concentration on the Intracellular Cyst(e)ine Concentration in Macrophages and on the Capacity to Release CysteineBiological Chemistry Hoppe-Seyler, 1989
- Low Concentrations of Acid-Soluble Thiol (Cysteine) in the Blood Plasma of HIV-1-Infected PatientsBiological Chemistry Hoppe-Seyler, 1989
- Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndromeThe American Journal of Medicine, 1988